Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry
Results 5961 - 500 out of 500 displayed.
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Reset ↻

MacroGenics Provides Update on Corporate Progress and 2023 Financial Results

Read more ››

By: GlobeNewswire - 07 Mar 2024

Related companies: MacroGenics, Inc.

Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate Update

Read more ››

By: GlobeNewswire - 07 Mar 2024

Related companies: Alpha Tau Medical Ltd.

argenx Delivers on Promise to Transform Patient Expectations in Autoimmunity at American Academy of Neurology 2024 Annual Meeting

Read more ››

By: GlobeNewswire - 07 Mar 2024

Related companies: argenx SE

Oncternal Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results

Read more ››

By: GlobeNewswire - 07 Mar 2024

Related companies: Oncternal Therapeutics, Inc.

ALX Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Read more ››

By: GlobeNewswire - 07 Mar 2024

Related companies: ALX Oncology, Inc.

Sight Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Initiates Full Year 2024 Financial Guidance

Read more ››

By: GlobeNewswire - 07 Mar 2024

Related companies: Sight Sciences, Inc.

Viracta Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Read more ››

By: GlobeNewswire - 07 Mar 2024

Related companies: Viracta Therapeutics, Inc.

ARS Pharmaceuticals Reviews Recent Clinical Updates and Commercial Opportunity at neffy® Investor Day

Read more ››

By: GlobeNewswire - 07 Mar 2024

Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024

Read more ››

By: GlobeNewswire - 07 Mar 2024

Related companies: Exagen Inc.

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

Read more ››

By: GlobeNewswire - 07 Mar 2024

Related companies: Terns Pharmaceuticals Inc.

Quoin Pharmaceuticals Announces Fourth Quarter and 2023 Financial Results and Corporate Update Conference Call to be held on Thursday March 14th at 8:30 am ET

Read more ››

By: GlobeNewswire - 07 Mar 2024

Related companies: Quoin Pharmaceuticals Ltd.

Kronos Bio Announces Restructuring to Focus Resources on Clinical Development with Extended Cash Runway

Read more ››

By: GlobeNewswire - 07 Mar 2024

Related companies: Kronos Bio, Inc.

Industry Veteran Clay Thornton Joins Clover Health as CFO of Medicare Advantage

Read more ››

By: GlobeNewswire - 07 Mar 2024

RadNet Announces Proposed $200 Million Underwritten Public Offering of Common Stock

Read more ››

By: GlobeNewswire - 07 Mar 2024

Related companies: RadNet, Inc

Xtant Medical Increases Revolving Credit Facility to $17 Million with MidCap Financial

Read more ››

By: GlobeNewswire - 07 Mar 2024

Related companies: Xtant Medical

IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Read more ››

By: GlobeNewswire - 07 Mar 2024

Related companies: IGM Biosciences, Inc.

Evoke Pharma to Report Fourth Quarter and Full Year 2023 Results on March 14, 2024

Read more ››

By: GlobeNewswire - 07 Mar 2024

Related companies: Evoke Pharma, Inc.

Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial Results

Read more ››

By: GlobeNewswire - 07 Mar 2024

Related companies: Nephros, Inc.

Scorpius Holdings, Inc. Announces Proposed Public Offering of Common Stock

Read more ››

By: GlobeNewswire - 07 Mar 2024

The Joint Corp. Reports Fourth Quarter and Year-end 2023 Financial Results

Read more ››

By: GlobeNewswire - 07 Mar 2024

« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

to the top ↑